An Evidence-Based Practice Approach to Evaluating Biotechnologically Derived Medications
摘要
Over the last 1–2 decades, a number of different therapeutic proteins have been developed using pharmaceutical biotechnology. This chapter uses six specific examples to show how using the best available evidence and the principles of shared-decision-making can lead to the appropriate use of these agents.